In recent years a new class of drugs has been developed which compel the body’s immune system to target specific attacking cells and bacteria. Called monoclonal antibodies (MABs) these drugs are engineered proteins that can be designed to target almost any attacking cell, such as cancer. In order to be effective large quantities are needed – usually delivered intravenously over several hours. However, if the proteins can be crystallised in space, the lack of gravity means that larger crystals can be developed a lot more efficiently. And larger protein crystals enables MAB treatments with higher concentrations – so that long intravenous procedure can be replaced with a simple injection, delivering the same exact dose.
🏢 Is this your organization?
We list organizations free for now. Claim this page to keep your details accurate and to receive enquiries sent from it by 4IRW visitors. Once we have verified you, we can update your details and add services, photos and prices.
Your request has been submitted successfully.
-
ARPA-H Funds AI-Driven Safer Herbicide D
Why AI is the New Frontier for Safer Herbicid.
-
WorldParticle model unifies simulation o
Why a single AI model could change the way en.
-
Cool Solar Panels Boost Efficiency in Ho
Why Solar Panels Overheat and How a Simple Co.
-
Fabric Molds Slash Concrete Use by One-T
Why fabric molds matter for concrete construc.
-
AI-discovered antibiotic wins Pritzker P
Breakthrough AI-Driven Antibiotic Earns the 2.
